We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+4.29%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$20.7B
AUM Growth
-$166M
Cap. Flow
-$582M
Cap. Flow %
-2.82%
Top 10 Hldgs %
30.44%
Holding
2,896
New
52
Increased
415
Reduced
1,909
Closed
89

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$65.1M
2
AAPL icon
Apple
AAPL
+$58M
3
MSFT icon
Microsoft
MSFT
+$49.2M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$25.9M
5
AL
Air Lease Corp
AL
+$21.6M

Sector Composition

Rank Sector Weight
1 Technology 30.28%
2 Financials 13.29%
3 Healthcare 10.43%
4 Consumer Discretionary 10.39%
5 Industrials 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATMU icon
976
Atmus Filtration Technologies
ATMU
$4.06B
$2.42M 0.01%
46,654
-2,033
-4% -$98.4K
WYNN icon
977
Wynn Resorts
WYNN
$10.5B
$2.42M 0.01%
20,101
-807
-4% -$99.8K
INDV icon
978
Indivior Pharmaceuticals
INDV
$4.51B
$2.41M 0.01%
67,247
-5,703
-8% -$174K
LSTR icon
979
Landstar System
LSTR
$6.4B
$2.41M 0.01%
16,777
-1,035
-6% -$138K
BYD icon
980
Boyd Gaming
BYD
$6.05B
$2.4M 0.01%
28,201
-2,248
-7% -$185K
AER icon
981
AerCap
AER
$23.5B
$2.4M 0.01%
16,700
-200
-1% -$26.5K
WK icon
982
Workiva
WK
$4.01B
$2.4M 0.01%
27,805
-1,474
-5% -$131K
TGTX icon
983
TG Therapeutics
TGTX
$7.34B
$2.4M 0.01%
80,434
-4,371
-5% -$143K
FORM icon
984
FormFactor
FORM
$10.3B
$2.39M 0.01%
42,793
-3,039
-7% -$153K
CDTX
985
DELISTED
Cidara Therapeutics
CDTX
$2.39M 0.01%
10,799
+1,465
+16% +$237K
OZK icon
986
Bank OZK
OZK
$5.7B
$2.38M 0.01%
51,749
-2,675
-5% -$125K
CORZ icon
987
Core Scientific
CORZ
$6.36B
$2.38M 0.01%
163,181
-3,100
-2% -$54.1K
LMND icon
988
Lemonade
LMND
$4.1B
$2.37M 0.01%
33,364
+1,008
+3% +$67.7K
MOH icon
989
Molina Healthcare
MOH
$10.7B
$2.37M 0.01%
13,653
-1,176
-8% -$193K
ST icon
990
Sensata Technologies
ST
$6.61B
$2.37M 0.01%
71,172
-3,672
-5% -$117K
BILL icon
991
BILL Holdings
BILL
$5.11B
$2.37M 0.01%
43,414
-3,739
-8% -$192K
LAUR icon
992
Laureate Education
LAUR
$5.15B
$2.36M 0.01%
70,178
-5,551
-7% -$171K
PBF icon
993
PBF Energy
PBF
$8.81B
$2.36M 0.01%
87,097
-3,754
-4% -$120K
BC icon
994
Brunswick
BC
$5.29B
$2.36M 0.01%
31,786
-1,795
-5% -$122K
BAX icon
995
Baxter International
BAX
$14B
$2.35M 0.01%
123,199
-4,214
-3% -$84.3K
CRL icon
996
Charles River Laboratories
CRL
$13.4B
$2.35M 0.01%
11,789
-410
-3% -$74.4K
ITRI icon
997
Itron
ITRI
$4.5B
$2.35M 0.01%
25,307
-1,313
-5% -$143K
NWSA icon
998
News Corp Class A
NWSA
$15.6B
$2.35M 0.01%
89,836
-3,599
-4% -$94.4K
FOLD
999
DELISTED
Amicus Therapeutics
FOLD
$2.34M 0.01%
164,210
-1,145
-0.7% -$11.2K
VSAT icon
1000
Viasat
VSAT
$11.4B
$2.34M 0.01%
67,835
-656
-1% -$23.2K

Similar funds

MetLife Investment Management's Q4 2025 Portfolio in Review

As of Q4 2025, MetLife Investment Management held 2,896 positions worth $20.7B, down 0.8% from $20.8B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q4 2025: portfolio turnover was 4.9%. MetLife Investment Management opened 52 new positions and exited 89, leaving the 2,896-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q4 2025 buy was RTX Corp: 321,368 shares worth $58.9M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $54.6M increase.
  • MetLife Investment Management's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $65.1M.
  • MetLife Investment Management fully exited Kellanova in Q4 2025, selling an estimated $5.48M.
  • MetLife Investment Management's ten largest holdings make up 30% of its $20.7B portfolio in Q4 2025.
  • MetLife Investment Management opened 52 new positions and closed 89 in Q4 2025.
  • MetLife Investment Management's portfolio value fell 0.8% quarter-over-quarter to $20.7B.

Based on MetLife Investment Management's 13F filing for Q4 2025, filed 12 Feb 2026.